← All trials
NCT01464034
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2011
- Primary completion
- Dec 1, 2019
- Completion date
- Jun 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 117
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Academic Myeloma ConsortiumLead sponsor
- Criterium, Inc.Collaborator
- AmgenCollaborator
- Academic Myeloma ConsortiumOverall official - principal investigator
- CelgeneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.